These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38247182)

  • 21. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
    Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of ischaemic burden in angiographic three-vessel coronary artery disease with high-resolution myocardial perfusion cardiovascular magnetic resonance imaging.
    Motwani M; Maredia N; Fairbairn TA; Kozerke S; Greenwood JP; Plein S
    Eur Heart J Cardiovasc Imaging; 2014 Jun; 15(6):701-8. PubMed ID: 24493156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare presentation of cardiac amyloid deposits isolated to intramural vessels.
    Clemmensen TS; Mølgaard H; Andersen NF; Baerentzen S; Soerensen J; Poulsen SH
    Echocardiography; 2016 Nov; 33(11):1777-1780. PubMed ID: 27600369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
    Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
    J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of stress perfusion CMR in comparison with quantitative coronary angiography: fully quantitative, semiquantitative, and qualitative assessment.
    Mordini FE; Haddad T; Hsu LY; Kellman P; Lowrey TB; Aletras AH; Bandettini WP; Arai AE
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):14-22. PubMed ID: 24433707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular magnetic resonance findings in repaired anomalous left coronary artery to pulmonary artery connection (ALCAPA).
    Secinaro A; Ntsinjana H; Tann O; Schuler PK; Muthurangu V; Hughes M; Tsang V; Taylor AM
    J Cardiovasc Magn Reson; 2011 May; 13(1):27. PubMed ID: 21575211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of Fractional Flow Reserve With Ischemic Burden Measured by Cardiovascular Magnetic Resonance Perfusion Imaging.
    Hussain ST; Paul M; Morton G; Schuster A; Chiribiri A; Perera D; Nagel E
    Am J Cardiol; 2017 Dec; 120(11):1913-1919. PubMed ID: 29050683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
    Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
    Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
    Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects.
    Brown LAE; Onciul SC; Broadbent DA; Johnson K; Fent GJ; Foley JRJ; Garg P; Chew PG; Knott K; Dall'Armellina E; Swoboda PP; Xue H; Greenwood JP; Moon JC; Kellman P; Plein S
    J Cardiovasc Magn Reson; 2018 Jul; 20(1):48. PubMed ID: 29983119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of cardiovascular magnetic resonance and single photon emission computed tomography (SPECT) perfusion imaging in left main stem or equivalent coronary artery disease: a CE-MARC substudy.
    Foley JRJ; Kidambi A; Biglands JD; Maredia N; Dickinson CJ; Plein S; Greenwood JP
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):84. PubMed ID: 29110669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
    Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
    Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular magnetic resonance profiling of coronary atherosclerosis: vessel wall remodelling and related myocardial blood flow alterations.
    Jahnke C; Manka R; Kozerke S; Schnackenburg B; Gebker R; Marx N; Paetsch I
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1400-10. PubMed ID: 25104810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation.
    Pozo E; Castellano JM; Kanwar A; Deochand R; Castillo-Martin M; Pazos-López P; González-Lengua C; Osman K; Cham M; Cordon-Cardo C; Narula J; Fuster V; Sanz J
    J Card Fail; 2018 Feb; 24(2):78-86. PubMed ID: 28801077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
    Banypersad SM; Sado DM; Flett AS; Gibbs SD; Pinney JH; Maestrini V; Cox AT; Fontana M; Whelan CJ; Wechalekar AD; Hawkins PN; Moon JC
    Circ Cardiovasc Imaging; 2013 Jan; 6(1):34-9. PubMed ID: 23192846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis.
    Ta AD; Hsu LY; Conn HM; Winkler S; Greve AM; Shanbhag SM; Chen MY; Patricia Bandettini W; Arai AE
    J Cardiovasc Magn Reson; 2018 Mar; 20(1):16. PubMed ID: 29514708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
    Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing transmural myocardial perfusion with CMR.
    Klocke FJ; Lee DC
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):23-5. PubMed ID: 24433708
    [No Abstract]   [Full Text] [Related]  

  • 40. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits.
    Bravo PE; Fujikura K; Kijewski MF; Jerosch-Herold M; Jacob S; El-Sady MS; Sticka W; Dubey S; Belanger A; Park MA; Di Carli MF; Kwong RY; Falk RH; Dorbala S
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1165-1173. PubMed ID: 30121266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.